Geoff Meacham
Stock Analyst at Citigroup
(3.56)
# 769
Out of 4,829 analysts
240
Total ratings
50%
Success rate
3.42%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTCT PTC Therapeutics | Upgrades: Neutral | $50 → $40 | $45.88 | -12.81% | 8 | May 7, 2025 | |
| BNTX BioNTech SE | Maintains: Buy | $145 → $140 | $94.51 | +48.13% | 2 | May 6, 2025 | |
| NMRA Neumora Therapeutics | Downgrades: Underperform | $7 → $1 | $0.74 | +35.54% | 3 | Apr 2, 2025 | |
| MRNA Moderna | Initiates: Neutral | $40 | $25.12 | +59.24% | 10 | Mar 13, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Buy | $52 | $32.19 | +61.54% | 4 | Mar 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $26.68 | +49.93% | 3 | Mar 13, 2025 | |
| RNA Avidity Biosciences | Initiates: Buy | $70 | $29.15 | +140.14% | 4 | Mar 13, 2025 | |
| APGE Apogee Therapeutics | Initiates: Buy | $95 | $40.23 | +136.14% | 2 | Mar 13, 2025 | |
| ETNB 89bio | Initiates: Buy | $25 | $8.20 | +204.88% | 1 | Mar 13, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $99 → $103 | $61.29 | +68.05% | 3 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $160 → $145 | $124.00 | +16.94% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $215 | $187.82 | +14.47% | 16 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $795 → $750 | $570.82 | +31.39% | 20 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $272.94 | +8.08% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $37.15 | +128.80% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.45 | +175.86% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $35.26 | +27.62% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $101.94 | +22.62% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $435.80 | +31.94% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $725.01 | +51.72% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 → $1 | $0.41 | +142.66% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $11.10 | +179.28% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.35 | +2,790.17% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $78.84 | +83.92% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $153.36 | +10.85% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $32.85 | +15.69% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $25.96 | +84.90% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $47.30 | +26.85% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.18 | +577.97% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $5.33 | +162.66% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $3.62 | +120.99% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $0.75 | +2,171.21% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $14 | $1.00 | +1,300.00% | 3 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $22.74 | +97.89% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $4.86 | +928.81% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.88 | +1,176.60% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $4.63 | -13.61% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.41 | +1,885.82% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.54 | +6,155.75% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.06 | +1,279.31% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $0.77 | +4,426.06% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $2.76 | +18,921.74% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $0.90 | +4,565.11% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $5.61 | +256.82% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.73 | +2,656.72% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $2.96 | +204.57% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $7.87 | +662.39% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.25 | +64.71% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $11.81 | +94.83% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $60.30 | +36.00% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $307.22 | -69.08% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $10.81 | +640.06% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $119.20 | +13.26% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $7.74 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.76 | +2,525.71% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $20.90 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $255.37 | -38.13% | 5 | Nov 8, 2017 |
PTC Therapeutics
May 7, 2025
Upgrades: Neutral
Price Target: $50 → $40
Current: $45.88
Upside: -12.81%
BioNTech SE
May 6, 2025
Maintains: Buy
Price Target: $145 → $140
Current: $94.51
Upside: +48.13%
Neumora Therapeutics
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.74
Upside: +35.54%
Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $25.12
Upside: +59.24%
Kymera Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $52
Current: $32.19
Upside: +61.54%
Kiniksa Pharmaceuticals International,
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $26.68
Upside: +49.93%
Avidity Biosciences
Mar 13, 2025
Initiates: Buy
Price Target: $70
Current: $29.15
Upside: +140.14%
Apogee Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $40.23
Upside: +136.14%
89bio
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $8.20
Upside: +204.88%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $61.29
Upside: +68.05%
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $124.00
Upside: +16.94%
Feb 3, 2025
Maintains: Buy
Price Target: $205 → $215
Current: $187.82
Upside: +14.47%
Jan 28, 2025
Maintains: Neutral
Price Target: $795 → $750
Current: $570.82
Upside: +31.39%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $272.94
Upside: +8.08%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $37.15
Upside: +128.80%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.45
Upside: +175.86%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $35.26
Upside: +27.62%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $101.94
Upside: +22.62%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $435.80
Upside: +31.94%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $725.01
Upside: +51.72%
Oct 30, 2024
Downgrades: Underperform
Price Target: $6 → $1
Current: $0.41
Upside: +142.66%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $11.10
Upside: +179.28%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.35
Upside: +2,790.17%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $78.84
Upside: +83.92%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $153.36
Upside: +10.85%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $32.85
Upside: +15.69%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $25.96
Upside: +84.90%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $47.30
Upside: +26.85%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.18
Upside: +577.97%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $5.33
Upside: +162.66%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $3.62
Upside: +120.99%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $0.75
Upside: +2,171.21%
Jul 20, 2023
Reinstates: Buy
Price Target: $14
Current: $1.00
Upside: +1,300.00%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $22.74
Upside: +97.89%
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $4.86
Upside: +928.81%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.88
Upside: +1,176.60%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $4.63
Upside: -13.61%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.41
Upside: +1,885.82%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.54
Upside: +6,155.75%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.06
Upside: +1,279.31%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $0.77
Upside: +4,426.06%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $2.76
Upside: +18,921.74%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $0.90
Upside: +4,565.11%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $5.61
Upside: +256.82%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.73
Upside: +2,656.72%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $2.96
Upside: +204.57%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $7.87
Upside: +662.39%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.25
Upside: +64.71%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $11.81
Upside: +94.83%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $60.30
Upside: +36.00%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $307.22
Upside: -69.08%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $10.81
Upside: +640.06%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $119.20
Upside: +13.26%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $7.74
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.76
Upside: +2,525.71%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $20.90
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $255.37
Upside: -38.13%